Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/21461
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWong, Eric-
dc.contributor.authorDavis, Joanne-
dc.contributor.authorKoldej, Rachel-
dc.contributor.authorSzer, Jeff-
dc.contributor.authorGrigg, Andrew-
dc.contributor.authorRitchie, David-
dc.date2019-
dc.date.accessioned2019-08-12T05:00:19Z-
dc.date.available2019-08-12T05:00:19Z-
dc.date.issued2019-08-07-
dc.identifier.citationLeukemia & lymphoma 2019: online first: 7 August-
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/21461-
dc.language.isoeng-
dc.titleNivolumab induces dynamic alterations in CD8 T-cell function and TIM-3 expression when used to treat relapsed acute myeloid leukemia after allogeneic stem cell transplantation.-
dc.typeJournal Article-
dc.identifier.journaltitleLeukemia & lymphoma-
dc.identifier.affiliationDepartment of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australiaen
dc.identifier.affiliationDepartment of Clinical Oncology, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australiaen
dc.identifier.affiliationAustralian Cancer Research Foundation Translation Research Laboratory, Sydney, Australiaen
dc.identifier.affiliationOlivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia-
dc.identifier.doi10.1080/10428194.2019.1648803-
dc.identifier.pubmedid31389281-
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.